Goodwin Procter advised Cerevel Therapeutics on the deal. Cerevel Therapeutics (Nasdaq: CERE) announced its underwritten public offering of 14,000,000 shares of common stock at a public offering...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Goodwin Procter LLP advised Centessa Pharmaceuticals on the deal. Centessa Pharmaceuticals, a clinical-stage company employing its innovative asset-centric business model...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Chiasma, Inc. on the deal. Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Roman DBDR, while Morgan, Lewis & Bockius LLP advised CompoSecure on the deal. Simpson Thacher served as counsel to the placement agents....
You must be a Standard 1 Year member to access this content.
Vinson & Elkins LLP advised TPG Pace Tech Opportunities on the deal while Goodwin Procter LLP advised Nerdy Inc. on the deal. TPG Pace Tech Opportunities...
You must be a Standard 1 Year member to access this content.
